Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Staphylococcus aureus bivalent (types 5 and 8) conjugate vaccine - Nabi

Next Previous
X
Search
Drug Profile

Staphylococcus aureus bivalent (types 5 and 8) conjugate vaccine - Nabi

Alternative Names: S. aureus type 5 & 8 capsular polysaccharide conjugate vaccine - Nabi; Staphylococcus aureus polysaccharide conjugate vaccine bivalent - Nabi; Nabi-StaphVAX; StaphVAX-Bivalent

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nabi Biopharmaceuticals; National Institutes of Health (USA)
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 31 Mar 2006 Nabi Biopharmaceuticals has resumed development of the Staphylococcus aureus vaccine conjugate following a positive review by an outside advisory panel
  • 04 Nov 2005 Nabi Biopharmaceuticals withdrawn its MAA for StaphVAX® for the prevention of Staphylococcal infections in patients with end-stage renal disease in the European Union
  • 04 Nov 2005 Clinical data from a media release have been added to the Bacterial Infections immunogenicity section

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top